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commissurotomyAbstract Background: Rheumatic cardiac disease is an immunologic phenomenon that may affect
any of the heart valves and is by far the most common cause of mitral stenosis.
Aim of the work: To evaluate impact of successful percutaneous balloon mitral valvuloplasty on
right ventricular function.
Subjects and methods: 30 consecutive patients who underwent balloon mitral valvuloplasty for
rheumatic mitral stenosis between September 2010 and July 2011 at Ain Shams University hospital
were included.
All patients were subjected to transthoracic echo Doppler study, tissue Doppler imaging and TEE
for: (A) Assessment of severity of mitral stenosis. (B) Peak myocardial velocities during systole,
early and late diastole. (C) Assessment of RV function by measurement of TAPSE and Tie index.
Results: The study revealed a signiﬁcant drop in TAPSE (before and 24 h after, P 0.008; before and
3 ms after, P 0.001) respectively. There was no signiﬁcant change 24 h and 3 ms after the procedure
(P 0.220) .There was no signiﬁcant change in IVC ﬂow before and after 24 h (P 0.221). There was no
signiﬁcant drop between before and after 3 ms (P 0.062). There was no signiﬁcant change between
24 h and 3 ms after the procedure (P 0.264). There was a signiﬁcant drop in Tie index (before and
24 h after, P 0.008; before and 3 ms after, P 0.009) respectively but no signiﬁcant drop was found
24 h and 3 ms after the procedure (P 0.373).
Conclusion: The current study showed a signiﬁcant improvement in both systolic and diastolic
functions of RV as observed by different echocardiographic parameters post BMV in patients with-
out organic TV disease.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Rheumatic cardiac disease is an immunologic phenomenon
that may affect any of the heart valves and the myocardium
and is by far the most common cause of mitral stenosis.1
Mitral stenosis leads to increase in left atrial pressure which
results in a passive rise in pulmonary venous and arterial pres-
sures.2 It eventually leads to right ventricular dilatation and
34 A. Morttada et al.failure. Thus, right ventricular dysfunction is an important
indicator to evaluate the severity of mitral stenosis.3
The quantitative echocardiographic assessment of right
ventricular function is difﬁcult because of the ventricle’s com-
plex trapezoidal anatomy and narrow acoustic window.
Two dimensional echocardiography is the mainstay for analysis
of RV function, but recently alternative techniques have been pro-
posed, including tissue Doppler imaging (TDI) techniques, three
dimensional echocardiography, magnetic resonance imaging
(MRI), and even invasive assessment of pressure–volume loops.4
The morphologic information provided by echocardiogra-
phy is important for evaluating potential candidates for percu-
taneous balloon valvuloplasty.5
2. Subjects and methods
Thirty consecutive patients who underwent balloon mitral val-
vuloplasty for rheumatic mitral stenosis between September
2010 and July 2011 at the Ain Shams University Hospital were
included in this study. All patients who were included in the
study had formal written consent.
2.1. Inclusion criteria
 Sinus rhythm.
 All the patients were in New York Heart classPII or 6IV.
 Moderate to severe MS (i.e., a mitral valve area 61 cm2/m2
body surface area (BSA) or <1.5 cm2 in normal-sized
adults.6
 Suitable valve morphology by echocardiographic criteria.
 Absence of concomitant cardiovascular disease requiring
surgical correction.2.2. Exclusion criteria
 Atrial ﬁbrillation.
 Systemic hypertension.
 Diabetes mellitus.
 More than mild mitral or aortic regurgitation and/or aortic
stenosis.
 Lung diseases.
 Pulmonary valve disease.
 New York Heart Association functional class IV.
 Previous aortic or mitral valve surgery.
 Echocardiographic criteria for contraindications of balloon
valvuloplasty e.g. mitral regurgitation grade III or IV, left
atrial thrombus, heavily calciﬁed mitral valve annulus, com-
missural calciﬁcation and heavy subvalvular affection).7
 Organic tricuspid valve affection.Figure 1 Tissue Doppler echocardiography (DTI) time intervals
measured from the tricuspid lateral annulus. ECG: Electrocardio-
gram; IVCT: isovolumic contraction time; IVRT: isovolumic
relaxation time; S: systolic velocity; En: early diastolic velocity; An:
late diastolic velocity; ET: ejection time; DT: E-wave deceleration
time.102.3. Echocardiographic measurement
 All patients were examined in the left lateral decubitus posi-
tion by M-mode, two-dimensional, Doppler and DTI echo-
cardiography with the use of Vivid 5GE echocardiography
device with a 2.5 MHz transducer.
 The Wilkins score was used to assess the suitability of the
mitral valve’s morphology for balloon mitral valvuloplasty.
This scoring system assigns a point value from 1 to 4 for
each of: (1) Valve calciﬁcation, (2) leaﬂet mobility, (3) leaﬂet
thickening, and (4) disease of the subvalvular apparatus.82.4. Severity of mitral stenosis was assessed by
 Mitral valve area was calculated by both the pressure
half-time method and planimetry.6
 Peak and mean diastolic transmitral gradients were mea-
sured by continuous-wave Doppler echocardiography.
 Continuous wave Doppler is used to estimate pulmonary
artery systolic and mean diastolic pressure by measuring
the peak retrograde pressure drop across the tricuspid valve
(Tricuspid regurgitation) and pulmonary valve (Pulmonary
regurgitation), respectively. Tricuspid valve velocities can
be obtained from parasternal short or long axis projection
and apical view whereas pulmonary valve velocities are
obtained from the parasternal short axis views (Fig. 1).
The pressure drop (gradient) is calculated from the ﬂow
velocity using the modiﬁed Bernoulli formula (DP= 4V2).9
 The maximum peak TR velocity (V) was used to determine
right ventricular systolic pressure (RVSP) with the simpli-
ﬁed Bernoulli equation which is the sum of the trans-
tricuspid gradient and right atrial pressure (RAP)
{RVSP = 4V2 + RAP}. V is the maximal velocity of the
tricuspid regurgitant jet). We further assumed a right atrial
mean pressure of 10 mmHg in patients, based on the
absence of inferior vena cava dilation greater than 20 mm.11
In the absence of a gradient across the pulmonic valve or
RVOT, SPAP is equal to RVSP.12
2.5. Assessment of RV function
2.5.1. Using M-mode
The tricuspid annular plane systolic excursion (TAPSE) was
measured by the level of systolic excursion of the lateral tricus-
pid valve annulus towards the apex in the four chamber view4
(see Fig. 2)
Figure 2 TAPSE.13
Percutaneous balloon mitral valvuloplasty on right ventricular function 352.5.2. Doppler tissue imaging
In the apical four-chamber view, the DTI cursor was placed at
the tricuspid annulus of the RV free wall.
Three major velocities were recorded: the positive systolic
velocity S when the tricuspid ring moved towards the cardiac
apex, and two negative diastolic velocities En and An when
the mitral and tricuspid annulus moved towards the base away
from the apex. Systolic indexes of DTI included myocardial
peak velocity of S, IVCT (from the onset of ECG QRS to
the beginning of S), IVRT: isovolumic relaxation time; the
time interval occurring between the end of S and the onset
of En wave and ET (from the beginning to the end of S-wave).
Diastolic indexes included En and An peak velocities.10
The Tei index of RV myocardial performance was calcu-
lated as the time between tricuspid valve closure and tricuspid
valve opening, divided by the RV ejection time and obtained
from the tricuspid annulus as the sum of IVCT and IVRT di-
vided by ET3
Tie index ¼ IVCTþ IVRT
ET
Peak myocardial velocities during systole and diastole together
with the isovolumic contraction velocity will be measured.11
The previous echocardiographic parameters were repeated
24–48 h post BMV and after 3 months for follow up.
2.6. Exclusion of other valvular lesion
2.6.1. Exclusion of complications after PBMV
Percutaneous balloon mitral valvuloplasty was performed
using the antegrade double balloon technique
 Balloon size was chosen according to the mitral annular
diameter (measured by echocardiography) as follows: sum
of diameters of the two balloons equals mitral annular
diameter.14
 All antegrade approaches begin with the crucial ﬁrst step of
successful trans-septal catheterization with successful access
to left atrium through proper part of the atrial septum to
allow easy access to the mitral valve then placement of a
Mullins type dilator and sheath into LA.15
 The two balloon-dilating catheters were then advanced over
each of the guide-wires and positioned across the mitral
valve parallel to the longitudinal axis of the left ventricle
and the Mullins sheath dilator system was removed.The balloon valvotomy catheters were then inﬂated by hand
until the indentation produced by the stenotic mitral valve
is no longer seen. Generally one but occasionally two or
three inﬂations were performed. After complete deﬂation
the balloons were removed sequentially.17
 Right and left heart haemodynamic data were recorded
before and after the procedure. The results were assessed
in the cath. lab by invasive measurement of the mean dia-
stolic pressure gradient across the mitral valve.14
 Echocardiography was done at the end of the procedure to
ensure successful balloon dilatation and to exclude compli-
cations as perforation, more than II/IV MR and an atrial
left-to-right shunt using colour ﬂow Doppler.
 Successful balloon mitral valvuloplasty criteria are:
o 50–60% reduction in transmitral gradient.
o MVA greater than 1.5 cm2.
o A decrease in left atrial pressure to less than 18 mmHg
in the absence of complications.7
o All of the above criteria were used to assess the success
of the procedure.
2.7. Statistical analysis
Statistical presentation and analysis of the present study were
conducted, using the mean, standard error, paired t-test, Chi-
square and Linear Correlation Coefﬁcient and by SPSS V17.
3. Results
The study included 30 patients {5 males (16.67%) and 25
females (83.33%)}.
3.1. Age
Patients’ age ranged from 16 to 54 (mean 30.10 ± 9.286 years).
3.2. Weight
Patients’ weight ranged from 52 to 68 kg (59.53 ± 3.821).
3.3. Height
Patients’ height ranged from 150.00 to 168.000 cm
(158.400 ± 3.821).
All the patients were in sinus rhythm with no history or
signs of hypertension, diabetes mellitus or lung disease. Major-
ity of patients were in NYHA class II (22 patients; 73.33%)
and (8 patients; 26.66%) in NYHA class III.
3.3.1. Transthoracic echocardiography data
Ejection fraction was normal in all the patients, There was no
tricuspid regurgitation more than grade II (that remained at
the same grade post BMV) or pulmonary valve disease (regur-
gitation or stenosis) or mitral regurgitation more than grade II.
The mean Wilkin’s score was 7.76 ± 0.31. The mean MVA by
planimetry was 0.893 ± 0.297 cm2 and by PHT was
0.918 ± 0.221 cm2. There was a signiﬁcant correlation be-
tween MVA by planimetry and MVA by PHT. The mean
36 A. Morttada et al.transmitral pressure gradient was 13.967 ± 5.38 while the
peak was 27.00 ± 7.551 mmHg.
The mean value of pulmonary systolic arterial pressure
(SPAP) was 63.833 ± 19.855 mmHg. Mean TAPSE was
22.32 ± 4.0 mm.
3.3.2. By using tissue Doppler
Mean isovolumic contraction velocity (IVV) was
11.19 ± 4.21 cm/s, mean S velocity was 12.78 ± 3.21
cm/s, En velocity was 9.397 ± 2.385, An velocity was
(12.962 ± 3.009) cm/s and Tie index was (0.502 ± 0.093).
No atrial or atrial appendage thrombus was detected in all
patients before the procedure by using TEE. Reassessment of
mitral valve score and evaluation of MR was also done by
TEE. Balloon size was chosen according to mitral valve annu-
lus measurement by TEE.
Successful BMV was done for all selected patients without
any evidence of cardiac perforation and no more than grade II
mitral regurgitation was detected by echo Doppler.
There was signiﬁcant increase in MVA between before and
after 24 h where t= 17.610 and P-value < 0.001 and by PHT
t= 20.152 and P-value < 0.001 There was signiﬁcant increase
between before and after 3 ms where t= 20.920 and
P-value < 0.001 and by PHT t= 24.414 and P-value <
0.001. There was no signiﬁcant change between the area 24 h
after and the area either by planimetry or PHT after 3 ms,
where t= 0.931 and P-value = 0.360 and t= 0.618 and
P-value = 0.541 respectively.
There was signiﬁcant drop in mean and peak PG before and
24 h post BMV where t= 3.325 and P-value = 0.002;
t= 11.095 and P-value < 0.001 respectively. There was signif-
icant drop in mean PG and peak PG before and after 3 ms
where t= 3.379 and P-value = 0.002; t= 11.179 and
P-value < 0.001 respectively. There was signiﬁcant drop in
mean PG and peak PG 24 h post BMV and after 3 ms where
t= 1.033 and P-value = 0.310 and by t= 0.834 and P-va-
lue = 0.411 respectively.
3.4. Systolic pulmonary artery pressure (SPAP)
Table 1 showed signiﬁcant drop in SPAP before and after 24 h
where t= 8.162 and P-value < 0.001. There was signiﬁcant
drop in SPAP before and after 3 ms where t= 11.965 and
P-value < 0.001. There was no signiﬁcant change in SPAP be-
tween 24 h after the procedure and 3 months later where
t= 1.489 and P-value = 0.147.
Table 2 shows a signiﬁcant drop in TAPSE before and 24 h
after;before and 3 ms after) the procedure where t= 2.831 and
P-value = 0.008; t= 3.593 and P-value = 0.001 respectively.
There was no signiﬁcant change 24 h and 3 ms after the proce-
dure where t= 17.610 and P-value = 0.220.
There was no signiﬁcant change in IVC ﬂow before and
after 24 h where t= 1.251 and P-value = 0.221.There was
no signiﬁcant drop between before and after 3 ms where
t= 2.028 and P-value = 0.062 .There was no signiﬁcant
change between 24 h and 3 ms after the procedure where
t= 1.139 and P-value = 0.264.
No signiﬁcant drop was found in S velocity (before and
24 h after;before and 3 ms after) where t= 0.785 and
P-value = 0.439; t= 1.380 and P-value = 0.178 respectivelybut a slight signiﬁcant drop occurred 24 h and 3 ms after the
procedure where t= 2.068 and P-value = 0.048.
No signiﬁcant increase was found in En velocity (before and
24 h after; before and 3 ms after) where t= 2.820 and
P-value = 0.009; t= 2.440 and P-value = 0.021 respectively
but there was no signiﬁcant increase 24 h and 3 ms after the
procedure where t= 1.797 and P-value = 0.083.
There was no signiﬁcant drop in An velocity (before and
24 h after; before and 3 ms after) where t= 0.675 and
P-value = 0.505; t= 0.349 and P-value = 0.729 respectively
but a slight signiﬁcant drop occurred 24 h and 3 ms after the
procedure where t= 2.961 and P-value = 0.006.
Table 3 shows a signiﬁcant drop in Tie index (before and
24 h afterbefore and 3 ms after) where t= 2.850 and
P-value = 0.008; t= 2.801 and P-value = 0.009 respectively
but no signiﬁcant drop occurred 24 h and 3 ms after the proce-
dure where t= 0.904 and P-value = 0.373.
Table 4 showed signiﬁcant correlation between MVA by
planimetry with (MVA by PHT, mean pressure, SPAP,
E&A) and no relation with the other parameters.
Table 5 showed signiﬁcant correlation between Tie index
with (SPAP, TAPSE and En vel.) and no relation with the
other parameters.4. Discussion
In the current study, the above mentioned parameters were
compared before BMV, (24–48 h) post BMV and 3 m after
the procedure to assess the impact of successful BMV on right
ventricular functions.
In the current study, SPAP showed a signiﬁcant decrease
between (before and after 24 h; before and after 3 ms); but
no signiﬁcance between (after 24 h and after 3 ms) occurred
due to a sudden increase in the mitral valve area which caused
a sudden decrease in the pressure gradient across the mitral
valve leading to a decrease in left atrial pressure, pulmonary
venous congestion and pulmonary artery pressure. This causes
acute decrease in RV afterload which has a drawback on the
contractile function of RV. Also in the current study SPAP
showed signiﬁcant negative correlation with MVA
(r= 0.542, P= 0.002) after BMV. As well, there was a po-
sitive correlation between Tie index and systolic pulmonary ar-
tery pressure. This was concordant with the study by Drighil
et al.11 which included 21 patients who demonstrated a signif-
icant decrease in SPAP post BMV and a positive correlation
between Tie index and pulmonary artery systolic pressure be-
fore BMV. Also, Arat et al.’s10 study on 56 patients who
underwent PMBV for isolated rheumatic MS with assessment
of RV function before PMBV, 48 h and 3 months after PMBV
noted that SPAP was still relatively higher in the intermediate
follow up period in patients with baseline PAH compared to
patients without baseline PAH, but the difference was not sta-
tistically signiﬁcant.
The decline in SPAP after the procedure was attributable to
decreased afterload inpatients with baseline PAH, while pa-
tients without PAH exhibited increases in systolic function
parameters even though their afterload values seemed to be
much lower. It has been reported that pulmonary pressure usu-
ally normalizes within 6 months, but may stay elevated for
more than 2 years in some patients 10.
Table 1 Change in SPAP (mmHg) before and after BMV.
SPAP Paired t-test
Range Mean ± SD t P-value
Before 35.00–120.00 63.833 ± 19.855 Before–After 24 h 8.162 <0.001*
After 24 h 20.00–85.00 39.000 ± 14.916 Before–After 3 ms 11.965 <0.001*
After 3 ms 20.00–85.00 36.333 ± 12.383 After 24 h–After 3 ms 1.489 0.147
Table 2 Change in TAPSE (mm) before and after BMV.
TAPSE Paired t-test
Range Mean ± SD t P-value
Before 10.00–32.00 22.320 ± 4.005 Before–After 24 h 2.831 0.008
After 24 h 15.00–28.00 20.657 ± 2.878 Before–After 3 ms 3.593 0.001
After 3 ms 15.00–24.00 20.167 ± 2.493 After 24 h–After 3 ms 1.255 0.220
Table 3 Change in Tie index before and after BMV.
Tie Paired t-test
Range Mean ± SD t P-value
Before 0.320–0.70 0.502 ± 0.093 Before–After 24 h 2.850 0.008*
After 24hr 0.300–0.61 0.463 ± 0.086 Before–After 3 ms 2.801 0.009*
After 3 ms 0.300–0.61 0.455 ± 0.082 After 24 h–After 3 ms 0.904 0.373
Table 4 Correlation between MVA by planimetry and other
parameters before BMV.
MVA by planimetry
r P-value
MVA by (PHT) 0.909 <0.001
Mean pr. 0.658 <0.001
Peak pr. 0.036 0.851
SPAP 0.542 0.002
TAPSE 0.122 0.521
IVV 0.255 0.174
S 0.137 0.469
En 0.436 0.016
An 0.436 0.016
Tie 0.135 0.476
Wilkin’s score 0.167 0.377
Table 5 Correlation between Tie index and other parameters
before MV.
Tie
r P-value
MVA by (PHT) 0.052 0.784
Mean pr. 0.073 0.701
Peak pr. 0.031 0.871
SPAP 0.444 0.014*
TAPSE 0.390 0.033*
IVV 0.280 0.133
S 0.007 0.971
En 0.333 0.072*
An 0.130 0.494
Wilkin’s score 0.105 0.581
Percutaneous balloon mitral valvuloplasty on right ventricular function 37TAPSE is one of the parameters which reﬂect systolic func-
tion of RV. In the current study TAPSE showed signiﬁcant de-
crease between (before and after 24 h; before and after 3 ms);
but no signiﬁcance occurred between after 24 h and after
3 ms; and shows non signiﬁcant relation with MVA
(r= 0.122, P= 0.521). This was concordant with the study
by Mahfouz et al.16 which included 147 patients in rheumatic
MS. This study revealed a signiﬁcant decrease in TAPSE post
BMV denoting that the RV function is usually impaired (even
subclinical) in those patients inspite of mild pulmonary hyper-
tension. In accordance with these results, Drighil et al.11 sug-
gested that patients with MS have depressed global and
regional RV function compared with normal subjects; ﬁndingsgo hand in hand with previous radionuclide and haemody-
namic studies.
On the other hand, Adavane et al.’s18 by a study on 33 pa-
tients with MS before BMV, 24–48 h after BMV and 1 month
after BMV assessed echocardiographic parameters of RV
function which showed a signiﬁcant increase of TAPSE
(P= 0.01 immediately after BMV; P< 0.001 at 1 month)
and a signiﬁcant correlation with the decrease in PVR, RV-
RA pressure gradient, the immediate decrease in MVG, and
the increase in MVA at one month. In patients with
MVA> 1.5 cm2 after BMV, successful BMV results in a
signiﬁcant improvement of RV systolic function assessed by
TAPSE.
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(IVV) on the lateral side of the tricuspid annulus showed no
signiﬁcant decrease between before and 24 h post BMV. There
was no signiﬁcant decrease between before and after 3 months
and (24 h and 3 ms) after BMV. Also, there was no signiﬁcant
correlation with MVA (r= 0.255, P= 0.174) and a negative
correlation with SPAP (r= 0.372, P= 0.043). In contrast,
Tayyareci et al. (2008)3 study on 112 patients with rheumatic
MS, found IVV to be signiﬁcantly decreased and did not cor-
relate with those traditional indices.
In the current study, S velocity showed no signiﬁcant drop
in (before and 24 h after) and (before and 3 ms after) with a
slight signiﬁcant drop (24 h and 3 ms) after the procedure.
On the other hand Tayyareci et al.3 study found S velocity
to be signiﬁcantly decreased with no correlation with the other
parameters. This was not concordance with Drighil et al.11
study where S velocity remained unchanged and revealed the
reason why systolic velocities during ejection period at the lat-
eral tricuspid annulus remained stable after PTMC, whereas
IVA and isovolumic contraction velocity decrease may be re-
lated to the fact that parameters illustrating isovolumic con-
traction period may be more sensitive markers of myocardial
function than systolic velocities during the ejection period.
On the other hand, the study by Arat et al.10 showed that
the peak systolic (S) velocity of the lateral tricuspid annulus
did not differ between the two groups (pts with PAH and pts
with no PAH) at baseline. In patients with pulmonary artery
hypertension (PAH), it showed a slight increase at 48 h, but fell
behind the baseline at 3 months. In patients without PAH, it
showed a signiﬁcant increase at 48 h and remained unchanged
at 3 months.
A change in the RV S-wave velocity only in patients with-
out PAH, which might be due to a more protected RV func-
tion in this particular group. Another confounding factor
might be the shortness of the follow-up period, which was only
3 months. Similar RV changes might be expected within a
longer follow-up period in patients with baseline PAH, but this
needs to be clariﬁed by further studies 10.
In the current study, En velocity showed a signiﬁcant in-
crease in (before and 24 h after) and (before and 3 ms after)
with no signiﬁcant increase 24 h and 3 ms after the procedure.
An velocity showed no signiﬁcant drop in (before and 24 h
after) and (before and 3 ms after) with a slight signiﬁcant drop
24 h and 3 ms after the procedure .This was concordant with
Mahfouz et al.16 where their study showed the same result.
On the other hand Arat et al.10 study showed that E- and
A-wave peak velocities did not differ signiﬁcantly at 48 h
and 3 months.
On the other hand Mehta et al.19 noticed a non-signiﬁcant
increase in RV free wall annular velocities in 25 patients stud-
ied following PBMV and concluded that RV dysfunction per-
sists in the period immediately following BMV despite
signiﬁcant changes in pulmonary artery pressures, and this
could explain the persistence of right sided congestion in some
of these patients.
The previous two studies were relatively disconcordant with
the current study.
Diastolic functions of RV may deteriorate in the presence
of normal systolic functions in symptomatic patients with iso-
lated mitral stenosis.20 Good correlation between RV diastolic
dysfunction (and not systolic dysfunction) and increased
pulmonary artery systolic pressure has been demonstratedindicating RV systolic dysfunction to be the result of pulmon-
ary hypertension, disturbance of myocardial microcirculation
and myocardial ﬁbrosis. These ﬁndings suggest that RV dia-
stolic dysfunction is the ﬁrst detectable myocardial manifesta-
tion of inﬂammatory process.21
In the current study, Tie index showed a signiﬁcant drop
(before and 24 h post BMV; before and 3 ms after BMV) but
no signiﬁcant drop occurred (24 h and 3 ms) after BMV. Also,
Tie index showed no signiﬁcant correlation with changes in
MVA. As well, there was a positive correlation between Tie in-
dex and systolic pulmonary artery pressure. This result was
concordant with Drighil et al.11. On the other hand, Arat
et al.10 showed that, the baseline Tie index was higher in pa-
tients with PAH (P= 0.004) and no signiﬁcant difference in
the Tie index during 3-month follow-up. Evaluation at
3 months showed that the Tie index of patients with baseline
PAH decreased to values similar to those of patients without
baseline PAH. In contrast, Mohan et al.21studied 25 consecu-
tive patients with isolated rheumatic mitral stenosis before,
immediately after (mean, 40 ± 12 h) and at a mean follow-
up of 11.5 months after PTMC. The Tie index was not affected
immediately after successful PTMC, however, at follow-up of
about one year, the Tie index showed a signiﬁcant decrease.
The Doppler index of combined right ventricular function
was signiﬁcantly correlated with the mean pulmonary artery
pressure and systolic pulmonary artery pressure before PTMC
and also immediately after the procedure; however, at follow-
up, the index had no correlation with the Doppler estimated
pulmonary artery systolic pressure.
The drop in RV Tie index and systolic pulmonary artery
pressure together immediately post-BMV suggest that RV out-
ﬂow tract systolic function improved as a result of an acute de-
crease in RV afterload. This is concordant with the study by
Borges et al.22 who demonstrated an improvement in Tie index
after vasodilator therapy in patients with chronic pulmonary
hypertension Drighil et al.115. Conclusion
The current study showed a signiﬁcant improvement in both
systolic and diastolic function of RV as observed by different
echocardiographic parameters post BMV in patients without
organic TV disease.6. Recommendations
There is a need to measure RV ejection fraction (RVEF) and
RV fractional area. Also RV outﬂow tract fraction shortening
(RVOTfs) should be measured as it reﬂects the infundibular
function.
Isovolumic acceleration (IVA) should be measured as it
correlates positively with global LV and RV contractility.
Further work using larger numbers of patients is needed to
conﬁrm our ﬁndings and to assess their utility in patient’s fol-
low-up and management.
7. Limitation
The main limitation of the current study is the small number of
patients examined. This was due to the exclusion criteria,
Percutaneous balloon mitral valvuloplasty on right ventricular function 39which aimed to limit the number of confounding factors that
might interfere with RV function. Another limitation is the
short term follow up.
Further studies with large patient groups and long-term fol-
low-up are needed for assessment of the clinical effects of these
changes on RV functions.
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